{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:34:58Z","timestamp":1791995698025,"version":"4.4.0"},"reference-count":39,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2003,9,30]],"date-time":"2003-09-30T00:00:00Z","timestamp":1064880000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2003,10]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Aims<\/jats:bold> : To determine the impact of gastro\u2010oesophageal reflux disease (GERD) on the quality of life, to assess changes in the quality of life during treatment with esomeprazole and to define factors that can predict these changes.<\/jats:p><jats:p><jats:bold>Methods<\/jats:bold> : Patients with GERD (<jats:italic>n<\/jats:italic>\u2003=\u20036215) were included in a prospective cohort study (ProGERD). All patients underwent endoscopy and received esomeprazole. At baseline and after 2\u2003weeks of treatment, symptoms and quality of life were assessed. Factors that influenced changes in the quality of life were determined by multiple regression analyses.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold> : At baseline, the quality of life in GERD patients was lower than that in the general population, and was similar to that in patients after acute coronary events. No differences in symptoms or quality of life were observed between the subgroups of patients with non\u2010erosive GERD, erosive GERD and Barrett's oesophagus. After treatment with esomeprazole, the symptoms and quality of life were improved in all subscales within 2\u2003weeks (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001). The mean score of the disease\u2010specific quality of life instrument (Quality of Life in Reflux and Dyspepsia Patients) increased from 4.6 to 6.2 points, representing a highly relevant clinical improvement. The generic quality of life (SF\u201036) reached levels similar to those in the general population, but, again, no difference was found between the three different subgroups of GERD patients. The main factors associated with an improvement in the quality of life after treatment were symptom relief, severe erosive reflux disease, absence of extra\u2010oesophageal disorders, avoidance of non\u2010steroidal anti\u2010inflammatory drug intake and positive <jats:italic>Helicobacter pylori<\/jats:italic> status.<\/jats:p><jats:p><jats:bold>Conclusions<\/jats:bold> : GERD causes a significant impairment in the quality of life that can be attenuated or normalized within a time period as short as 2\u2003weeks by treatment with esomeprazole. These findings were similar across the whole GERD patient spectrum.<\/jats:p>","DOI":"10.1046\/j.1365-2036.2003.01770.x","type":"journal-article","created":{"date-parts":[[2004,12,19]],"date-time":"2004-12-19T09:26:12Z","timestamp":1103448372000},"page":"767-776","source":"Crossref","is-referenced-by-count":196,"title":["Quality of life in relation to symptoms in patients with gastro\u2010oesophageal reflux disease \u2014 an analysis based on the ProGERD initiative"],"prefix":"10.1111","volume":"18","author":[{"given":"M.","family":"Kulig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Leodolter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Vieth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Schulte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Jaspersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Labenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Lind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Meyer\u2010Sabellek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Malfertheiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Stolte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. N.","family":"Willich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,9,30]]},"reference":[{"key":"e_1_2_14_2_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529609094759"},{"key":"e_1_2_14_3_2","doi-asserted-by":"publisher","DOI":"10.1159\/000200911"},{"key":"e_1_2_14_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01071906"},{"key":"e_1_2_14_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.44.2008.S1"},{"key":"e_1_2_14_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199903183401101"},{"key":"e_1_2_14_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7271.1252"},{"key":"e_1_2_14_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200106000-00005"},{"key":"e_1_2_14_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(01)00745-8"},{"key":"e_1_2_14_10_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005468332122"},{"key":"e_1_2_14_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.01861.x"},{"issue":"5","key":"e_1_2_14_12_2","first-page":"257","article-title":"Why do apparently healthy people use antacid tablets?","volume":"78","author":"Graham DY","year":"1983","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_14_13_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529309098272"},{"key":"e_1_2_14_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199806000-00002"},{"issue":"1","key":"e_1_2_14_15_2","first-page":"19","article-title":"Quality of life during acute and intermittent treatment of gastro\u2010oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial. The European Study Group","volume":"30","author":"Wiklund I","year":"1998","journal-title":"Ital J Gastroenterol Hepatol"},{"key":"e_1_2_14_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)00354-9"},{"key":"e_1_2_14_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00669.x"},{"key":"e_1_2_14_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.01206.x"},{"key":"e_1_2_14_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.02235.x"},{"key":"e_1_2_14_20_2","doi-asserted-by":"publisher","DOI":"10.1159\/000016878"},{"key":"e_1_2_14_21_2","unstructured":"KuligM LeodolterA NoconM et al.Patients with gastroesophageal reflux disease \u2014 design and first epidemiologic results of the ProGERD study.J Clin Epidemiol2003in press."},{"key":"e_1_2_14_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.45.2.172"},{"key":"e_1_2_14_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03451.x"},{"key":"e_1_2_14_24_2","first-page":"41","article-title":"Quality of Life in Reflux and Dyspepsia Patients. Psychometric documentation of a new disease\u2010specific questionnaire (QOLRAD)","volume":"583","author":"Wiklund IK","year":"1998","journal-title":"Eur J Surg Suppl"},{"key":"e_1_2_14_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03932.x"},{"key":"e_1_2_14_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199206000-00002"},{"key":"e_1_2_14_27_2","volume-title":"SF\u201036 Health Survey. Manual and Interpretation Guide.","author":"Ware JE","year":"1993"},{"key":"e_1_2_14_28_2","volume-title":"SF\u201036 Physical and Mental Summary Scales: A User's Manual.","author":"Ware JE","year":"1994"},{"key":"e_1_2_14_29_2","first-page":"1359","article-title":"German translation and psychometric testing of the SF\u201036 Health Survey: preliminary results from the IQOLA Project","volume":"41","author":"Bullinger M","year":"1995","journal-title":"Int Quality Life Assessment Soc Sci Med"},{"key":"e_1_2_14_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.316.7132.690"},{"key":"e_1_2_14_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00435226"},{"key":"e_1_2_14_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-198903001-00015"},{"key":"e_1_2_14_33_2","volume-title":"Statistical Power Analysis for the Behavioural Sciences","author":"Cohen J","year":"1988"},{"key":"e_1_2_14_34_2","volume-title":"Der SF\u201036 Fragebogen zum Gesundheitszustand. Handbuch f\u00fcr die Deutschsprachige Fragebogenversion.","author":"Bullinger M","year":"1998"},{"key":"e_1_2_14_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(98)00108-5"},{"key":"e_1_2_14_36_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7118.1273"},{"key":"e_1_2_14_37_2","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.2000.2294"},{"key":"e_1_2_14_38_2","unstructured":"M\u00fcller\u2010NordhornJ KuligM BintingS et al.for the PIN Study Group.Change in quality of life in the year following cardiac rehabilitation \u2014 is it clinically relevant and what are its predictors?Qual Life Res2003in press."},{"key":"e_1_2_14_39_2","first-page":"649","article-title":"Measuring gastroesophageal reflux disease: relationship between the health\u2010related quality of life and physiologic parameters","volume":"64","author":"Velanovich V","year":"1998","journal-title":"Am Surg"},{"key":"e_1_2_14_40_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.1.45"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2003.01770.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2003.01770.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.2003.01770.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T20:55:43Z","timestamp":1697230543000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.2003.01770.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9,30]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2003,10]]}},"alternative-id":["10.1046\/j.1365-2036.2003.01770.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.2003.01770.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,9,30]]}}}